BCRX

| Held by: VTI XBI IWM VB VXF IWO IBB VBK CALF SCHA

Index	RUT	P/E	-	EPS (ttm)	-1.78	Insider Own	9.72%	Shs Outstand	254.01M	Perf Week	4.64%
Market Cap	2.29B	Forward P/E	28.79	EPS next Y	0.31	Insider Trans	-1.89%	Shs Float	229.77M	Perf Month	-5.25%
Enterprise Value	2.91B	PEG	-	EPS next Q	0.16	Inst Own	83.74%	Short Float	16.28%	Perf Quarter	33.43%
Income	-457.98M	P/S	2.59	EPS this Y	-321.28%	Inst Trans	5.85%	Short Ratio	6.78	Perf Half Y	25.63%
Sales	885.72M	P/B	-	EPS next Y	111.70%	ROA	-96.92%	Short Interest	37.42M	Perf YTD	15.64%
Book/sh	-2.18	P/C	9.58	EPS next 5Y	-29.26%	ROE	-	52W High	11.31 -20.25%	Perf Year	-11.66%
Cash/sh	0.94	P/FCF	7.82	EPS past 3/5Y	- -	ROIC	-175.59%	52W Low	6.00 50.33%	Perf 3Y	2.85%
Dividend Est.	-	EV/EBITDA	9.15	Sales past 3/5Y	47.82% 117.89%	Gross Margin	97.52%	Volatility	5.92% 5.22%	Perf 5Y	-29.75%
Dividend TTM	-	EV/Sales	3.29	EPS Y/Y TTM	-569.22%	Oper. Margin	35.67%	ATR (14)	0.47	Perf 10Y	209.97%
Dividend Ex-Date	-	Quick Ratio	1.88	Sales Y/Y TTM	75.92%	Profit Margin	-51.71%	RSI (14)	49.15	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.91	EPS Q/Q	-2979600.00%	SMA20	0.37%	Beta	0.59	Target Price	21.30
Payout	0.00%	Debt/Eq	-	Sales Q/Q	7.48%	SMA50	-1.70%	Rel Volume	0.83	Prev Close	9.57
Employees	435	LT Debt/Eq	-	Earnings	May 06 BMO	SMA200	14.10%	Avg Volume	5.52M	Price	9.02
IPO	Mar 04, 1994	Option/Short	Yes / Yes	EPS/Sales Surpr.	-6826.86% 3.50%	Trades		Volume	4,572,572	Change	-5.75%

Biocryst Pharmaceuticals Inc

Upgrade your Finviz experience